Pierre Gantner

3.8k total citations
35 papers, 488 citations indexed

About

Pierre Gantner is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Pierre Gantner has authored 35 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Infectious Diseases, 19 papers in Virology and 9 papers in Epidemiology. Recurrent topics in Pierre Gantner's work include HIV Research and Treatment (19 papers), HIV/AIDS drug development and treatment (14 papers) and HIV/AIDS Research and Interventions (10 papers). Pierre Gantner is often cited by papers focused on HIV Research and Treatment (19 papers), HIV/AIDS drug development and treatment (14 papers) and HIV/AIDS Research and Interventions (10 papers). Pierre Gantner collaborates with scholars based in France, Canada and United States. Pierre Gantner's co-authors include Nicolas Chomont, Rémi Fromentin, Samira Fafi‐Kremer, Marion Pardons, Caroline Dufour, Aurélie Velay, Morgane Solis, Amélie Pagliuzza, Jean‐Pierre Routy and Moti Ramgopal and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Immunity.

In The Last Decade

Pierre Gantner

32 papers receiving 482 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pierre Gantner France 12 276 255 102 97 66 35 488
Angela M. Mexas United States 14 370 1.3× 589 2.3× 357 3.5× 151 1.6× 32 0.5× 23 844
Barbara Falkensammer Austria 13 203 0.7× 112 0.4× 166 1.6× 69 0.7× 33 0.5× 31 431
Kimberli A. Schmidt United States 15 325 1.2× 371 1.5× 142 1.4× 398 4.1× 66 1.0× 25 697
Agnès-Laurence Chenine United States 14 201 0.7× 475 1.9× 266 2.6× 187 1.9× 39 0.6× 28 641
Leo Heyndrickx Belgium 17 448 1.6× 463 1.8× 103 1.0× 135 1.4× 49 0.7× 36 624
Anna S. Nishiya Brazil 12 219 0.8× 146 0.6× 34 0.3× 265 2.7× 129 2.0× 40 505
Elaine Raniero Fernandes Brazil 13 254 0.9× 104 0.4× 83 0.8× 146 1.5× 250 3.8× 32 492
Helene Mens Denmark 11 304 1.1× 248 1.0× 81 0.8× 95 1.0× 33 0.5× 41 491
Christine Sadorge France 10 91 0.3× 128 0.5× 65 0.6× 139 1.4× 56 0.8× 15 356
Iskra Tuero United States 13 92 0.3× 132 0.5× 187 1.8× 108 1.1× 24 0.4× 25 440

Countries citing papers authored by Pierre Gantner

Since Specialization
Citations

This map shows the geographic impact of Pierre Gantner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Gantner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Gantner more than expected).

Fields of papers citing papers by Pierre Gantner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Gantner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Gantner. The network helps show where Pierre Gantner may publish in the future.

Co-authorship network of co-authors of Pierre Gantner

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Gantner. A scholar is included among the top collaborators of Pierre Gantner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Gantner. Pierre Gantner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wirden, Marc, Marie‐Laure Chaix, Stéphanie Marque‐Juillet, et al.. (2025). Benefits of HIV‐1 transmission cluster surveillance: a French retrospective observational study of the molecular and epidemiological co‐evolution of recent circulating recombinant forms 94 and 132. Journal of the International AIDS Society. 28(2). e26416–e26416. 1 indexed citations
2.
Lin, Li‐Yun, Pierre Gantner, Shuang Li, Bin Su, & Christiane Moog. (2024). Unpredicted Protective Function of Fc-Mediated Inhibitory Antibodies for HIV and SARS-CoV-2 Vaccines. The Journal of Infectious Diseases. 231(1). e1–e9.
3.
Ruch, Yvon, Anne Fuchs, David Rey, et al.. (2024). Two Cases of Viral Re-suppression After M184V + R263K Selection on Dolutegravir/Lamivudine Without Treatment Modification. Clinical Infectious Diseases. 79(1). 198–201. 6 indexed citations
4.
Tripon, Simona, Pierre Gantner, Elodie Laugel, et al.. (2024). Impact of anti-HDV reflex testing at HBs antigen positive discovery in a single center France: Support for primary HDV screening in France. Journal of Clinical Virology. 171. 105650–105650. 6 indexed citations
5.
Glady, Ludovic, Gaëlle Gonzalez, Marie-Josée Wendling, et al.. (2024). Incidence of tick-borne encephalitis (TBE) in the pediatric population at the University Hospitals of Strasbourg (HUS) and characterization of confirmed cases. Journal of NeuroVirology. 30(5-6). 534–544.
6.
Fafi‐Kremer, Samira, et al.. (2023). Antigen specificities of HIV-infected cells: A role in infection and persistence?. Journal of Virus Eradication. 9(2). 100329–100329. 1 indexed citations
7.
Deng, Xiaoyan, Pierre Gantner, Amélie Pagliuzza, et al.. (2023). Plasma SARS‐CoV‐2 RNA elimination and RAGE kinetics distinguish COVID‐19 severity. Clinical & Translational Immunology. 12(11). e1468–e1468. 1 indexed citations
8.
Gantner, Pierre, Supranee Buranapraditkun, Amélie Pagliuzza, et al.. (2023). HIV rapidly targets a diverse pool of CD4+ T cells to establish productive and latent infections. Immunity. 56(3). 653–668.e5. 41 indexed citations
9.
Gallais, Floriane, Pierre Gantner, Delphine Planas, et al.. (2022). Case Report: Evolution of Humoral and Cellular Immunity in Two COVID-19 Breakthrough Infections After BNT162b2 Vaccine. Frontiers in Immunology. 13. 790212–790212. 2 indexed citations
10.
Gantner, Pierre, Wojciech Witkowski, Lennie Chen, et al.. (2021). In-depth single-cell analysis of translation-competent HIV-1 reservoirs identifies cellular sources of plasma viremia. Nature Communications. 12(1). 3727–3727. 45 indexed citations
11.
Gantner, Pierre, Clotilde Allavena, Claudine Duvivier, et al.. (2020). Post‐exposure prophylaxis completion and condom use in the context of potential sexual exposure to HIV*. HIV Medicine. 21(7). 463–469. 4 indexed citations
12.
Dufour, Caroline, Pierre Gantner, Rémi Fromentin, & Nicolas Chomont. (2020). The multifaceted nature of HIV latency. Journal of Clinical Investigation. 130(7). 3381–3390. 54 indexed citations
13.
Gantner, Pierre, Amélie Pagliuzza, Marion Pardons, et al.. (2020). Single-cell TCR sequencing reveals phenotypically diverse clonally expanded cells harboring inducible HIV proviruses during ART. Nature Communications. 11(1). 4089–4089. 69 indexed citations
14.
Gantner, Pierre, Laurence Morand‐Joubert, Pierre Frange, et al.. (2019). “Real life” use of raltegravir during pregnancy in France: The Coferal-IMEA048 cohort study. PLoS ONE. 14(4). e0216010–e0216010. 2 indexed citations
15.
Gantner, Pierre, Laurent Cotte, Clotilde Allavena, et al.. (2019). Higher rates of HBsAg clearance with tenofovir-containing therapy in HBV/HIV co-infection. PLoS ONE. 14(4). e0215464–e0215464. 18 indexed citations
16.
Gantner, Pierre, Cindy Barnig, Marialuisa Partisani, et al.. (2018). Distribution and reduction magnitude of HIV-DNA burden in CD4+ T cell subsets depend on art initiation timing. AIDS. 32(7). 921–926. 4 indexed citations
17.
Gantner, Pierre & Jade Ghosn. (2018). Genital reservoir. Current Opinion in HIV and AIDS. 13(5). 395–401. 6 indexed citations
18.
19.
Gantner, Pierre, Laurence Morand‐Joubert, François Raffi, et al.. (2015). Drug resistance and tropism as markers of the dynamics of HIV-1 DNA quasispecies in blood cells of heavily pretreated patients who achieved sustained virological suppression. Journal of Antimicrobial Chemotherapy. 71(3). 751–761. 21 indexed citations
20.
Gantner, Pierre, Marialuisa Partisani, Christine Cheneau, et al.. (2014). Efficacy and safety of switching to raltegravir plus atazanavir dual therapy in pretreated HIV-1-infected patients over 144 weeks: a cohort study. Scandinavian Journal of Infectious Diseases. 46(12). 838–845. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Angela M. Mexas Breakdown of academic impact, for papers by Barbara Falkensammer Breakdown of academic impact, for papers by Kimberli A. Schmidt Breakdown of academic impact, for papers by Agnès-Laurence Chenine Breakdown of academic impact, for papers by Leo Heyndrickx Breakdown of academic impact, for papers by Anna S. Nishiya Breakdown of academic impact, for papers by Elaine Raniero Fernandes Breakdown of academic impact, for papers by Helene Mens Breakdown of academic impact, for papers by Christine Sadorge Breakdown of academic impact, for papers by Iskra Tuero
Rankless by CCL
2026